Skip to main content

Curran Terrie's Form 4 filing

Myovant Sciences Ltd. (MYOV) · filed Sep 3, 2021

Accession no.
0001209191-21-054758
Filed
Sep 3, 2021
Trade date
Sep 1-2, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.21M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Curran TerrieCIK 0001690298Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2021Common SharesMOption exerciseAcquired+11,373$7.65+$87,003.4511,373Direct
Sep 1, 2021Common SharesSSaleDisposed−11,373$25.00F2−$284,3250Direct
Sep 2, 2021Common SharesMOption exerciseAcquired+37,135$7.65+$284,082.7537,135Direct
Sep 2, 2021Common SharesSSaleDisposed−37,135$25.03F3−$929,489.050Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 1, 2021Common SharesMOption exerciseDisposed−11,373$0.00$047,235Direct
Sep 2, 2021Common SharesMOption exerciseDisposed−37,135$0.00$010,100Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The shares were sold at prices ranging from $25.00 to $25.01. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The shares were sold at prices ranging from $25.00 to $25.10. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)